5 March 2015 - The release of the highly anticipated 2015 Intergenerational Report (IGR) today reaffirmed the growing body of evidence that shows that the Pharmaceutical Benefits Scheme is sustainable.

CEO of Medicines Australia, Tim James, welcomed the release of the Australian Government’s 2015 IGR, and its acknowledgement that growth in pharmaceutical expenditure will remain stable, growing only modestly to 2027-28.

“Medicines are central to achieving better health outcomes for the population. The flow on effects are increased participation and productivity, by people returning to work earlier and using medicines to avoid more costly and invasive treatments later on,” Mr James said.

The IGR showed that expenditure on pharmaceuticals is expected to grow from $420 per person in 2014-15 to $474 per person in 2027-28 (in today’s dollars).

“This is a major downward revision from the 2010 IGR.”

For more details, go to: https://medicinesaustralia.com.au/2015/03/05/igr-confirms-the-sustainability-of-the-pbs-into-the-future/